Report Overview
Noninvasive vaccine delivery systems need to incorporate an effective adjuvant, specially designed for triggering both mucosal and systemic immune responses.
The global Noninvasive Vaccination market size was estimated at USD 2670 million in 2023 and is projected to reach USD 4360.00 million by 2032, exhibiting a CAGR of 5.60% during the forecast period.
North America Noninvasive Vaccination market size was estimated at USD 764.12 million in 2023, at a CAGR of 4.80% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Noninvasive Vaccination market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Noninvasive Vaccination Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Noninvasive Vaccination market in any manner.
Global Noninvasive Vaccination Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
AstraZeneca
Cipla
BCHT
Market Segmentation (by Type)
Oral Vaccine
Nasal Spray Vaccine
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Noninvasive Vaccination Market
Overview of the regional outlook of the Noninvasive Vaccination Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Noninvasive Vaccination
1.2 Key Market Segments
1.2.1 Noninvasive Vaccination Segment by Type
1.2.2 Noninvasive Vaccination Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Noninvasive Vaccination Market Overview
2.1 Global Market Overview
2.1.1 Global Noninvasive Vaccination Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Noninvasive Vaccination Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Noninvasive Vaccination Market Competitive Landscape
3.1 Global Noninvasive Vaccination Sales by Manufacturers (2019-2025)
3.2 Global Noninvasive Vaccination Revenue Market Share by Manufacturers (2019-2025)
3.3 Noninvasive Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Noninvasive Vaccination Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Noninvasive Vaccination Sales Sites, Area Served, Product Type
3.6 Noninvasive Vaccination Market Competitive Situation and Trends
3.6.1 Noninvasive Vaccination Market Concentration Rate
3.6.2 Global 5 and 10 Largest Noninvasive Vaccination Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Noninvasive Vaccination Industry Chain Analysis
4.1 Noninvasive Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Noninvasive Vaccination Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Noninvasive Vaccination Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Noninvasive Vaccination Sales Market Share by Type (2019-2025)
6.3 Global Noninvasive Vaccination Market Size Market Share by Type (2019-2025)
6.4 Global Noninvasive Vaccination Price by Type (2019-2025)
7 Noninvasive Vaccination Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Noninvasive Vaccination Market Sales by Application (2019-2025)
7.3 Global Noninvasive Vaccination Market Size (M USD) by Application (2019-2025)
7.4 Global Noninvasive Vaccination Sales Growth Rate by Application (2019-2025)
8 Noninvasive Vaccination Market Consumption by Region
8.1 Global Noninvasive Vaccination Sales by Region
8.1.1 Global Noninvasive Vaccination Sales by Region
8.1.2 Global Noninvasive Vaccination Sales Market Share by Region
8.2 North America
8.2.1 North America Noninvasive Vaccination Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Noninvasive Vaccination Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Noninvasive Vaccination Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Noninvasive Vaccination Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Noninvasive Vaccination Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Noninvasive Vaccination Market Production by Region
9.1 Global Production of Noninvasive Vaccination by Region (2019-2025)
9.2 Global Noninvasive Vaccination Revenue Market Share by Region (2019-2025)
9.3 Global Noninvasive Vaccination Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Noninvasive Vaccination Production
9.4.1 North America Noninvasive Vaccination Production Growth Rate (2019-2025)
9.4.2 North America Noninvasive Vaccination Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Noninvasive Vaccination Production
9.5.1 Europe Noninvasive Vaccination Production Growth Rate (2019-2025)
9.5.2 Europe Noninvasive Vaccination Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Noninvasive Vaccination Production (2019-2025)
9.6.1 Japan Noninvasive Vaccination Production Growth Rate (2019-2025)
9.6.2 Japan Noninvasive Vaccination Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Noninvasive Vaccination Production (2019-2025)
9.7.1 China Noninvasive Vaccination Production Growth Rate (2019-2025)
9.7.2 China Noninvasive Vaccination Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Merck
10.1.1 Merck Noninvasive Vaccination Basic Information
10.1.2 Merck Noninvasive Vaccination Product Overview
10.1.3 Merck Noninvasive Vaccination Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck Noninvasive Vaccination SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Noninvasive Vaccination Basic Information
10.2.2 GSK Noninvasive Vaccination Product Overview
10.2.3 GSK Noninvasive Vaccination Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK Noninvasive Vaccination SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi
10.3.1 Sanofi Noninvasive Vaccination Basic Information
10.3.2 Sanofi Noninvasive Vaccination Product Overview
10.3.3 Sanofi Noninvasive Vaccination Product Market Performance
10.3.4 Sanofi Noninvasive Vaccination SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Noninvasive Vaccination Basic Information
10.4.2 Lanzhou Institute Noninvasive Vaccination Product Overview
10.4.3 Lanzhou Institute Noninvasive Vaccination Product Market Performance
10.4.4 Lanzhou Institute Business Overview
10.4.5 Lanzhou Institute Recent Developments
10.5 Serum Institute
10.5.1 Serum Institute Noninvasive Vaccination Basic Information
10.5.2 Serum Institute Noninvasive Vaccination Product Overview
10.5.3 Serum Institute Noninvasive Vaccination Product Market Performance
10.5.4 Serum Institute Business Overview
10.5.5 Serum Institute Recent Developments
10.6 Valneva
10.6.1 Valneva Noninvasive Vaccination Basic Information
10.6.2 Valneva Noninvasive Vaccination Product Overview
10.6.3 Valneva Noninvasive Vaccination Product Market Performance
10.6.4 Valneva Business Overview
10.6.5 Valneva Recent Developments
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Noninvasive Vaccination Basic Information
10.7.2 Shanghai United Cell Noninvasive Vaccination Product Overview
10.7.3 Shanghai United Cell Noninvasive Vaccination Product Market Performance
10.7.4 Shanghai United Cell Business Overview
10.7.5 Shanghai United Cell Recent Developments
10.8 Bibcol
10.8.1 Bibcol Noninvasive Vaccination Basic Information
10.8.2 Bibcol Noninvasive Vaccination Product Overview
10.8.3 Bibcol Noninvasive Vaccination Product Market Performance
10.8.4 Bibcol Business Overview
10.8.5 Bibcol Recent Developments
10.9 PaxVax
10.9.1 PaxVax Noninvasive Vaccination Basic Information
10.9.2 PaxVax Noninvasive Vaccination Product Overview
10.9.3 PaxVax Noninvasive Vaccination Product Market Performance
10.9.4 PaxVax Business Overview
10.9.5 PaxVax Recent Developments
10.10 Vabiotech
10.10.1 Vabiotech Noninvasive Vaccination Basic Information
10.10.2 Vabiotech Noninvasive Vaccination Product Overview
10.10.3 Vabiotech Noninvasive Vaccination Product Market Performance
10.10.4 Vabiotech Business Overview
10.10.5 Vabiotech Recent Developments
10.11 Tiantan Biological
10.11.1 Tiantan Biological Noninvasive Vaccination Basic Information
10.11.2 Tiantan Biological Noninvasive Vaccination Product Overview
10.11.3 Tiantan Biological Noninvasive Vaccination Product Market Performance
10.11.4 Tiantan Biological Business Overview
10.11.5 Tiantan Biological Recent Developments
10.12 EuBiologics
10.12.1 EuBiologics Noninvasive Vaccination Basic Information
10.12.2 EuBiologics Noninvasive Vaccination Product Overview
10.12.3 EuBiologics Noninvasive Vaccination Product Market Performance
10.12.4 EuBiologics Business Overview
10.12.5 EuBiologics Recent Developments
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Noninvasive Vaccination Basic Information
10.13.2 Panacea Biotec Ltd Noninvasive Vaccination Product Overview
10.13.3 Panacea Biotec Ltd Noninvasive Vaccination Product Market Performance
10.13.4 Panacea Biotec Ltd Business Overview
10.13.5 Panacea Biotec Ltd Recent Developments
10.14 Bio-Med
10.14.1 Bio-Med Noninvasive Vaccination Basic Information
10.14.2 Bio-Med Noninvasive Vaccination Product Overview
10.14.3 Bio-Med Noninvasive Vaccination Product Market Performance
10.14.4 Bio-Med Business Overview
10.14.5 Bio-Med Recent Developments
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Basic Information
10.15.2 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Overview
10.15.3 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Market Performance
10.15.4 Halfkin Bio-Pharmaceuticals Business Overview
10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
10.16 AstraZeneca
10.16.1 AstraZeneca Noninvasive Vaccination Basic Information
10.16.2 AstraZeneca Noninvasive Vaccination Product Overview
10.16.3 AstraZeneca Noninvasive Vaccination Product Market Performance
10.16.4 AstraZeneca Business Overview
10.16.5 AstraZeneca Recent Developments
10.17 Cipla
10.17.1 Cipla Noninvasive Vaccination Basic Information
10.17.2 Cipla Noninvasive Vaccination Product Overview
10.17.3 Cipla Noninvasive Vaccination Product Market Performance
10.17.4 Cipla Business Overview
10.17.5 Cipla Recent Developments
10.18 BCHT
10.18.1 BCHT Noninvasive Vaccination Basic Information
10.18.2 BCHT Noninvasive Vaccination Product Overview
10.18.3 BCHT Noninvasive Vaccination Product Market Performance
10.18.4 BCHT Business Overview
10.18.5 BCHT Recent Developments
11 Noninvasive Vaccination Market Forecast by Region
11.1 Global Noninvasive Vaccination Market Size Forecast
11.2 Global Noninvasive Vaccination Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Noninvasive Vaccination Market Size Forecast by Country
11.2.3 Asia Pacific Noninvasive Vaccination Market Size Forecast by Region
11.2.4 South America Noninvasive Vaccination Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Noninvasive Vaccination by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Noninvasive Vaccination Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Noninvasive Vaccination by Type (2025-2032)
12.1.2 Global Noninvasive Vaccination Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Noninvasive Vaccination by Type (2025-2032)
12.2 Global Noninvasive Vaccination Market Forecast by Application (2025-2032)
12.2.1 Global Noninvasive Vaccination Sales (K MT) Forecast by Application
12.2.2 Global Noninvasive Vaccination Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Noninvasive Vaccination Market Size Comparison by Region (M USD)
Table 5. Global Noninvasive Vaccination Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Noninvasive Vaccination Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Noninvasive Vaccination Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Noninvasive Vaccination Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Vaccination as of 2022)
Table 10. Global Market Noninvasive Vaccination Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Noninvasive Vaccination Sales Sites and Area Served
Table 12. Manufacturers Noninvasive Vaccination Product Type
Table 13. Global Noninvasive Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Noninvasive Vaccination
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Noninvasive Vaccination Market Challenges
Table 22. Global Noninvasive Vaccination Sales by Type (K MT)
Table 23. Global Noninvasive Vaccination Market Size by Type (M USD)
Table 24. Global Noninvasive Vaccination Sales (K MT) by Type (2019-2025)
Table 25. Global Noninvasive Vaccination Sales Market Share by Type (2019-2025)
Table 26. Global Noninvasive Vaccination Market Size (M USD) by Type (2019-2025)
Table 27. Global Noninvasive Vaccination Market Size Share by Type (2019-2025)
Table 28. Global Noninvasive Vaccination Price (USD/MT) by Type (2019-2025)
Table 29. Global Noninvasive Vaccination Sales (K MT) by Application
Table 30. Global Noninvasive Vaccination Market Size by Application
Table 31. Global Noninvasive Vaccination Sales by Application (2019-2025) & (K MT)
Table 32. Global Noninvasive Vaccination Sales Market Share by Application (2019-2025)
Table 33. Global Noninvasive Vaccination Sales by Application (2019-2025) & (M USD)
Table 34. Global Noninvasive Vaccination Market Share by Application (2019-2025)
Table 35. Global Noninvasive Vaccination Sales Growth Rate by Application (2019-2025)
Table 36. Global Noninvasive Vaccination Sales by Region (2019-2025) & (K MT)
Table 37. Global Noninvasive Vaccination Sales Market Share by Region (2019-2025)
Table 38. North America Noninvasive Vaccination Sales by Country (2019-2025) & (K MT)
Table 39. Europe Noninvasive Vaccination Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Noninvasive Vaccination Sales by Region (2019-2025) & (K MT)
Table 41. South America Noninvasive Vaccination Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Noninvasive Vaccination Sales by Region (2019-2025) & (K MT)
Table 43. Global Noninvasive Vaccination Production (K MT) by Region (2019-2025)
Table 44. Global Noninvasive Vaccination Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Noninvasive Vaccination Revenue Market Share by Region (2019-2025)
Table 46. Global Noninvasive Vaccination Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Noninvasive Vaccination Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Noninvasive Vaccination Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Noninvasive Vaccination Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Noninvasive Vaccination Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Merck Noninvasive Vaccination Basic Information
Table 52. Merck Noninvasive Vaccination Product Overview
Table 53. Merck Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Merck Business Overview
Table 55. Merck Noninvasive Vaccination SWOT Analysis
Table 56. Merck Recent Developments
Table 57. GSK Noninvasive Vaccination Basic Information
Table 58. GSK Noninvasive Vaccination Product Overview
Table 59. GSK Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. GSK Business Overview
Table 61. GSK Noninvasive Vaccination SWOT Analysis
Table 62. GSK Recent Developments
Table 63. Sanofi Noninvasive Vaccination Basic Information
Table 64. Sanofi Noninvasive Vaccination Product Overview
Table 65. Sanofi Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Sanofi Noninvasive Vaccination SWOT Analysis
Table 67. Sanofi Business Overview
Table 68. Sanofi Recent Developments
Table 69. Lanzhou Institute Noninvasive Vaccination Basic Information
Table 70. Lanzhou Institute Noninvasive Vaccination Product Overview
Table 71. Lanzhou Institute Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Lanzhou Institute Business Overview
Table 73. Lanzhou Institute Recent Developments
Table 74. Serum Institute Noninvasive Vaccination Basic Information
Table 75. Serum Institute Noninvasive Vaccination Product Overview
Table 76. Serum Institute Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Serum Institute Business Overview
Table 78. Serum Institute Recent Developments
Table 79. Valneva Noninvasive Vaccination Basic Information
Table 80. Valneva Noninvasive Vaccination Product Overview
Table 81. Valneva Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Valneva Business Overview
Table 83. Valneva Recent Developments
Table 84. Shanghai United Cell Noninvasive Vaccination Basic Information
Table 85. Shanghai United Cell Noninvasive Vaccination Product Overview
Table 86. Shanghai United Cell Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Shanghai United Cell Business Overview
Table 88. Shanghai United Cell Recent Developments
Table 89. Bibcol Noninvasive Vaccination Basic Information
Table 90. Bibcol Noninvasive Vaccination Product Overview
Table 91. Bibcol Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Bibcol Business Overview
Table 93. Bibcol Recent Developments
Table 94. PaxVax Noninvasive Vaccination Basic Information
Table 95. PaxVax Noninvasive Vaccination Product Overview
Table 96. PaxVax Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. PaxVax Business Overview
Table 98. PaxVax Recent Developments
Table 99. Vabiotech Noninvasive Vaccination Basic Information
Table 100. Vabiotech Noninvasive Vaccination Product Overview
Table 101. Vabiotech Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Vabiotech Business Overview
Table 103. Vabiotech Recent Developments
Table 104. Tiantan Biological Noninvasive Vaccination Basic Information
Table 105. Tiantan Biological Noninvasive Vaccination Product Overview
Table 106. Tiantan Biological Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Tiantan Biological Business Overview
Table 108. Tiantan Biological Recent Developments
Table 109. EuBiologics Noninvasive Vaccination Basic Information
Table 110. EuBiologics Noninvasive Vaccination Product Overview
Table 111. EuBiologics Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. EuBiologics Business Overview
Table 113. EuBiologics Recent Developments
Table 114. Panacea Biotec Ltd Noninvasive Vaccination Basic Information
Table 115. Panacea Biotec Ltd Noninvasive Vaccination Product Overview
Table 116. Panacea Biotec Ltd Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Panacea Biotec Ltd Business Overview
Table 118. Panacea Biotec Ltd Recent Developments
Table 119. Bio-Med Noninvasive Vaccination Basic Information
Table 120. Bio-Med Noninvasive Vaccination Product Overview
Table 121. Bio-Med Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Bio-Med Business Overview
Table 123. Bio-Med Recent Developments
Table 124. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Basic Information
Table 125. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Overview
Table 126. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Halfkin Bio-Pharmaceuticals Business Overview
Table 128. Halfkin Bio-Pharmaceuticals Recent Developments
Table 129. AstraZeneca Noninvasive Vaccination Basic Information
Table 130. AstraZeneca Noninvasive Vaccination Product Overview
Table 131. AstraZeneca Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. AstraZeneca Business Overview
Table 133. AstraZeneca Recent Developments
Table 134. Cipla Noninvasive Vaccination Basic Information
Table 135. Cipla Noninvasive Vaccination Product Overview
Table 136. Cipla Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Cipla Business Overview
Table 138. Cipla Recent Developments
Table 139. BCHT Noninvasive Vaccination Basic Information
Table 140. BCHT Noninvasive Vaccination Product Overview
Table 141. BCHT Noninvasive Vaccination Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. BCHT Business Overview
Table 143. BCHT Recent Developments
Table 144. Global Noninvasive Vaccination Sales Forecast by Region (2025-2032) & (K MT)
Table 145. Global Noninvasive Vaccination Market Size Forecast by Region (2025-2032) & (M USD)
Table 146. North America Noninvasive Vaccination Sales Forecast by Country (2025-2032) & (K MT)
Table 147. North America Noninvasive Vaccination Market Size Forecast by Country (2025-2032) & (M USD)
Table 148. Europe Noninvasive Vaccination Sales Forecast by Country (2025-2032) & (K MT)
Table 149. Europe Noninvasive Vaccination Market Size Forecast by Country (2025-2032) & (M USD)
Table 150. Asia Pacific Noninvasive Vaccination Sales Forecast by Region (2025-2032) & (K MT)
Table 151. Asia Pacific Noninvasive Vaccination Market Size Forecast by Region (2025-2032) & (M USD)
Table 152. South America Noninvasive Vaccination Sales Forecast by Country (2025-2032) & (K MT)
Table 153. South America Noninvasive Vaccination Market Size Forecast by Country (2025-2032) & (M USD)
Table 154. Middle East and Africa Noninvasive Vaccination Consumption Forecast by Country (2025-2032) & (Units)
Table 155. Middle East and Africa Noninvasive Vaccination Market Size Forecast by Country (2025-2032) & (M USD)
Table 156. Global Noninvasive Vaccination Sales Forecast by Type (2025-2032) & (K MT)
Table 157. Global Noninvasive Vaccination Market Size Forecast by Type (2025-2032) & (M USD)
Table 158. Global Noninvasive Vaccination Price Forecast by Type (2025-2032) & (USD/MT)
Table 159. Global Noninvasive Vaccination Sales (K MT) Forecast by Application (2025-2032)
Table 160. Global Noninvasive Vaccination Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Noninvasive Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Noninvasive Vaccination Market Size (M USD), 2019-2032
Figure 5. Global Noninvasive Vaccination Market Size (M USD) (2019-2032)
Figure 6. Global Noninvasive Vaccination Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Noninvasive Vaccination Market Size by Country (M USD)
Figure 11. Noninvasive Vaccination Sales Share by Manufacturers in 2023
Figure 12. Global Noninvasive Vaccination Revenue Share by Manufacturers in 2023
Figure 13. Noninvasive Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Noninvasive Vaccination Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Noninvasive Vaccination Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Noninvasive Vaccination Market Share by Type
Figure 18. Sales Market Share of Noninvasive Vaccination by Type (2019-2025)
Figure 19. Sales Market Share of Noninvasive Vaccination by Type in 2023
Figure 20. Market Size Share of Noninvasive Vaccination by Type (2019-2025)
Figure 21. Market Size Market Share of Noninvasive Vaccination by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Noninvasive Vaccination Market Share by Application
Figure 24. Global Noninvasive Vaccination Sales Market Share by Application (2019-2025)
Figure 25. Global Noninvasive Vaccination Sales Market Share by Application in 2023
Figure 26. Global Noninvasive Vaccination Market Share by Application (2019-2025)
Figure 27. Global Noninvasive Vaccination Market Share by Application in 2023
Figure 28. Global Noninvasive Vaccination Sales Growth Rate by Application (2019-2025)
Figure 29. Global Noninvasive Vaccination Sales Market Share by Region (2019-2025)
Figure 30. North America Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Noninvasive Vaccination Sales Market Share by Country in 2023
Figure 32. U.S. Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Noninvasive Vaccination Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Noninvasive Vaccination Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Noninvasive Vaccination Sales Market Share by Country in 2023
Figure 37. Germany Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Noninvasive Vaccination Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Noninvasive Vaccination Sales Market Share by Region in 2023
Figure 44. China Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Noninvasive Vaccination Sales and Growth Rate (K MT)
Figure 50. South America Noninvasive Vaccination Sales Market Share by Country in 2023
Figure 51. Brazil Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Noninvasive Vaccination Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Noninvasive Vaccination Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Noninvasive Vaccination Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Noninvasive Vaccination Production Market Share by Region (2019-2025)
Figure 62. North America Noninvasive Vaccination Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Noninvasive Vaccination Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Noninvasive Vaccination Production (K MT) Growth Rate (2019-2025)
Figure 65. China Noninvasive Vaccination Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Noninvasive Vaccination Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Noninvasive Vaccination Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Noninvasive Vaccination Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Noninvasive Vaccination Market Share Forecast by Type (2025-2032)
Figure 70. Global Noninvasive Vaccination Sales Forecast by Application (2025-2032)
Figure 71. Global Noninvasive Vaccination Market Share Forecast by Application (2025-2032)
